Bloomberg the Company & Products

Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us


Last 1,480 GBp
Change Today -35.00 / -2.31%
Volume 2.7M
As of 4:05 AM 05/7/15 All times are local (Market data is delayed by at least 15 minutes).

Executive Profile*

Moncef M. Slaoui Ph.D.

Chairman of Global Vaccines, Executive Director and Member of Finance Committee, GlaxoSmithKline plc
AgeTotal Calculated CompensationThis person is connected to 37 board members in 3 different organizations across 3 different industries.

See Board Relationships
54$4,333,000
As of Fiscal Year 2014

Background*

Dr. Moncef M. Slaoui, Ph.D. has been the Chairman of Global Vaccines at GlaxoSmithKline PLC since October 22, 2014. Dr. Slaoui serves as a Member of the Corporate Executive Team of GlaxoSmithKline, PLC. He served as the Chairman of Global Research and Development and Vaccines at GlaxoSmithKline PLC until October 22, 2014. He served as the Chairman of Research and Development at GlaxoSmithKline PLC since June 1, 2006 and leads the complex drug discovery and development ...

Read Full Background

Corporate Headquarters*

980 Great West Road
Brentford, Middlesex TW8 9GS

United Kingdom

Phone: 44 20 8047 5000
Fax: --

Board Members Memberships*

Former Director
Director and Member of Strategic Advisory Board
2006-Present
Chairman of Global Vaccines, Executive Director and Member of Finance Committee

Education*

PhD
Universite Libre de Bruxelles in Belgium
Master's Degree
Harvard Medical School
Master's Degree
Tufts University School of Medicine

Other Affiliations*

Annual Compensation*

Salary$1,212,000
Bonus$1,108,000
Total Annual Compensation$2,320,000

Stock Options*

Long Term Incentive Plan$1,077,000
All Other Compensation$936,000
Exercised Options26,800
Exercised Options Value78,792 GBP
Exercisable Options72,755
Total Value of Options78,792 GBP
Total Number of Options99,555

Total Compensation*

Total Annual Cash Compensation$3,256,000
Total Short Term Compensation$2,320,000
Other Long Term Compensation$936,000
Total Calculated Compensation$4,333,000
*Data is at least as current as the most recent Definitive Proxy.
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
GSK:LN 1,480.50 GBp -34.00

COMPETITOR COMPENSATION

NamePosition/
Company
Compensation
Giovanni Caforio M.D.Chief Executive Officer and Director
Bristol-Myers Squibb Company
$916.0K
Omar S. Ishrak Chairman and Chief Executive Officer
Medtronic plc
$1.5M
Brenton L. Saunders J.D.Chief Executive Officer, President and Director
Actavis plc
$500.0K
Marijn E. Dekkers Ph.D.Chairman of Management Board and Chief Executive Officer
Bayer AG
€3.2M
Richard A. Gonzalez Chairman, Chief Executive Officer and Chairman of Executive Committee
AbbVie Inc.
$1.6M
Compensation as of Fiscal Year 2014.

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact GLAXOSMITHKLINE PLC, please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.